Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy

Status unconfirmed · Phase 2

Conditions studied: Head and Neck Cancer

In brief

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be an effective palliative treatment for head and neck cancer. PURPOSE: Phase II trial to study the effectiveness of photodynamic therapy for palliative treatment in patients who have recurrent, refractory, or second primary head and neck cancer that cannot be treated with surgery or radiation therapy.

Key facts

Study ID

NCT00003856

Run by

Quintiles, Inc.

People needed

75

Starts

1998-10-01

Last updated by the study team

2013-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Division of Head and Neck Surgery — Evanston, Illinois, United States
• Norton Healthcare Pavilion — Louisville, Kentucky, United States
• Ear, Nose, and Throat Specialty Care of Minnesota, P.A. — Minneapolis, Minnesota, United States
• School of Dental Medicine — Buffalo, New York, United States
• St. Luke's-Roosevelt Hospital — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.